Aberdeen US Small Cap Equity C (GSXCX)

20.27 +0.66  +3.37% Mar 30 USD
View Full Chart
Total Returns Chart

Key Stats

Net Asset Value 20.27
Turnover Ratio 55.00%
1 Year Fund Level Flows -473.00M

Performance & Returns

  Total Return Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M -16.27% -18.19% 28
3M -23.68% -23.72% 51
6M -18.84% -16.71% 65
YTD -23.45% -23.90% 48
1Y -17.29% -16.91% 55
3Y -2.56% 2.15% 78
5Y 2.50% 2.86% 56
10Y 8.02% 8.82% 70
15Y 6.63% 7.20% 66
20Y 6.90% 5.45% --
As of March 30, 2020. Returns for periods of 1 year and above are annualized.

Asset Allocation

Type % Net % Long % Short
Cash 0.99% 0.99% 0.00%
Stock 99.01% 99.01% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 0.00% 0.00% 0.00%
As of Feb. 29, 2020

Region Exposure

Americas 100.0%
North America 100.0%
Latin America 0.00%
Greater Europe 0.00%
United Kingdom 0.00%
Europe Developed 0.00%
Europe Emerging 0.00%
Africa/Middle East 0.00%
Greater Asia 0.00%
Japan 0.00%
Australasia 0.00%
Asia Developed 0.00%
Asia Emerging 0.00%
Market Classification
% Developed Markets 100.0%
% Emerging Markets 0.00%
As of Feb. 29, 2020. Region breakdown data is calculated by using the long position holdings of the portfolio.

Stock Sector Exposure

Basic Materials 8.49%
Communication Services 0.00%
Consumer Cyclical 8.30%
Consumer Defensive 6.63%
Energy 0.00%
Financial Services 12.04%
Healthcare 15.98%
Industrials 21.62%
Real Estate 0.92%
Technology 24.52%
Utilities 1.49%
As of Feb. 29, 2020

Stock Market Capitalization

Giant 0.00%
Large 0.00%
Medium 29.05%
Small 67.71%
Micro 3.24%
As of Feb. 29, 2020

Stock Style Exposure

Large Cap Value 0.00%
Large Cap Blend 0.00%
Large Cap Growth 0.00%
Mid Cap Value 0.00%
Mid Cap Blend 9.33%
Mid Cap Growth 20.20%
Small Cap Value 9.47%
Small Cap Blend 33.45%
Small Cap Growth 27.55%
As of Feb. 29, 2020
View More Holdings

Top 10 Holdings

Symbol Name % Weight Price % Chg
GMED Globus Medical Inc Class A 2.85% 42.45 -0.56%
NP Neenah Inc 2.68% 42.68 +1.57%
LCII LCI Industries Inc 2.63% 66.67 +2.18%
FIVN Five9 Inc 2.61% 76.50 +0.29%
BJ BJ's Wholesale Club Holdings Inc 2.61% 24.20 -5.47%
ROCK Gibraltar Industries Inc 2.60% 42.90 +1.27%
MRCY Mercury Systems Inc 2.59% 71.34 -3.89%
HZNP Horizon Therapeutics PLC 2.55% 30.00 +2.21%
X.TO TMX Group Ltd 2.47% 104.77 -1.85%
KWR Quaker Chemical Corp 2.20% 125.91 -7.85%
As of Feb. 29, 2020
Advertisement

Basic Info

Investment Strategy
The investment seeks long-term capital appreciation. The fund normally invests at least 80% of the value of its net assets, plus any borrowings for investment purposes, in equity securities issued by U.S. small-cap companies. The advisor considers small-cap companies to be companies that have market capitalizations similar to those of companies included in the Russell 2000® Index at the time of investment. It also may invest in foreign securities and securities of larger companies.
General
Security Type Mutual Fund
Oldest Share Symbol GSXIX
Equity Style Small Cap/Growth
Fixed Income Style --
Broad Asset Class US Equity
Broad Category Equity
Category Name Small Growth
Prospectus Objective Small Company
Fund Owner Firm Name Aberdeen
Benchmark Index
Russell 2000 TR USD 100.0%
Reports
One Page Report Download

Manager Info

Name Tenure
Francis Radano 3.00 yrs
Jason Kotik 11.35 yrs
Ralph Bassett 11.35 yrs
Tim Skiendzielewski 0.61 yrs

Share Classes

Symbol Share Class
GNSRX Retirement
GSCIX Inst
GSXAX A
GSXIX Inst

Net Fund Flows

1M -11.12M
3M -40.16M
6M -107.44M
YTD -29.19M
1Y -473.00M
3Y -1.207B
5Y 263.78M
10Y 14.82M
As of Feb. 29, 2020

Risk Info

Beta (5Y) 1.022
Historical Sharpe Ratio (10Y) 0.7359
Historical Sortino (All) 0.5124
Daily Value at Risk (VaR) 1% (All) 3.64%
Monthly Value at Risk (VaR) 1% (All) 17.64%

Fundamentals

Dividend Yield TTM (3-30-20) 0.00%
30-Day SEC Yield --
7-Day SEC Yield --
Weighted Average PE Ratio 22.95
Weighted Average Price to Sales Ratio 1.385
Weighted Average Price to Book Ratio 2.674
Weighted Median ROE 11.96%
Weighted Median ROA 5.29%
Forecasted Dividend Yield 0.87%
Forecasted PE Ratio 19.38
Forecasted Price to Sales Ratio 1.328
Forecasted Price to Book Ratio 2.204
Number of Holdings 59
As of Feb. 29, 2020

Growth Estimates

Forecasted 5 Yr Earnings Growth 12.37%
Forecasted Book Value Growth 14.90%
Forecasted Cash Flow Growth 15.08%
Forecasted Earnings Growth 10.58%
Forecasted Revenue Growth 5.59%
As of Feb. 29, 2020

Comparables

Edit

Attributes

Purchase Details
Open to New Investors Yes
Open to Existing Investors Yes
Minimum Initial Investment 1000.00 USD
Minimum Subsequent Investment 50.00 USD
Fees
Actual 12B-1 Fee 1.00%
Actual Management Fee 0.81%
Administration Fee --
Performance Fee --
Switching Fee --
Transaction Fee --
Maximum Front Load --
Maximum Deferred Load 1.00%
Maximum Redemption Fee --
Key Dates
Inception Date 3/1/2001
Termination Date
Last Annual Report Date 10/31/2019
Last Prospectus Date 2/28/2020
Attributes
Exchange Traded Share No
Exchange Traded Note No
Enhanced Index Fund No
Fixed Distribution Fund No
High-Net Worth Individual Fund No
Index Fund No
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
Socially Responsible Fund Yes
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.